CLINWON™-T

Tretinoin  and Clindamycin is a well-established topical combination used in the management of acne vulgaris, designed to address both the inflammatory and comedonal components of acne in a complementary way. Tretinoin, a retinoid, works by normalizing follicular epithelial turnover, preventing the formation of microcomedones, and promoting gentle exfoliation that helps unclog pores and improve overall skin texture over time. Clindamycin, a lincosamide antibiotic, targets acne-causing bacteria, particularly Cutibacterium acnes, while also reducing inflammation and redness associated with active breakouts. Together, this dual-action approach helps reduce existing lesions and minimize the development of new ones, making it especially useful for mild to moderate acne. Dermapolis has combined these proven ingredients into its branded formulation, CLINWON™-T, developed with a focus on consistency, stability, and patient tolerability. CLINWON™-T is formulated to allow effective penetration of active ingredients while aiming to minimize common side effects such as excessive dryness or irritation when used as directed. With regular use under medical guidance, this combination can contribute to clearer skin, smoother texture, and a more even appearance, while supporting long-term acne control. As with all topical retinoid-antibiotic combinations, CLINWON™-T reflects a modern, evidence-based approach to acne management by Dermapolis, aligning therapeutic efficacy with a formulation designed for daily clinical practice and patient compliance.